散结膏方治疗轻度活动性甲状腺相关眼病的临床疗效观察OA
Clinical Efficacy Observation of Sanjie Medicinal Concoction in Paste Form(TCM)in Treating Thyroid Eye Disease
目的 观察在"缓消癥结"理论指导下散结膏方治疗轻度活动性甲状腺相关眼病(TED)的临床疗效.方法 纳入2023年3月—2024年3月于南京市中西医结合医院就诊的TED证属肝郁血阻证患者77例(149只眼),按照随机数字分成治疗组39例(75只眼)和对照组38例(74只眼).治疗组予散结膏方口服,对照组予逍遥丸口服,均治疗3个月.分别于治疗前后测量2组患者的Graves 眼病临床活动状态(CAS)评分、眼球突出度、睑裂高度、上睑退缩、眼睑闭合不全、瞬目次数、结膜充血评分、角膜荧光素染色(FL)评分、泪膜破裂时间(BUT)、泪液分泌试验(SⅠT)、眼表疾病指数(OSDI)评分、眼表面积(OSA).结果 (1)甲状腺功能:2组患者治疗前游离三碘甲状腺原氨酸(FT3)、血清游离甲状腺素(FT4)、促甲状腺激素(TSH)、甲状腺球蛋白抗体(TGAb)、甲状腺过氧化物酶抗体(TPOAb)及促甲状腺受体抗体(TRAb)比较,差异均无统计学意义(P>0.05).(2)TED相关指标:治疗组治疗后眼球突出度、睑裂高度、OSA、上睑退缩、眼睑闭合不全、CAS评分均低于治疗前,差异均有统计学意义(P<0.05);对照组治疗后TED相关6个指标与治疗前比较,差异均无统计学意义(P>0.05).治疗组治疗后TED相关6个指标均低于对照组,差异均有统计学意义(P<0.05).(3)干眼相关指标:治疗组治疗后BUT、SⅠT、瞬目频率、完全瞬目次数均高于治疗前,不完全瞬目次数、FL评分、OSDI评分及结膜充血评分均低于治疗前,差异均有统计学意义(P<0.05).对照组治疗后8个干眼相关指标与治疗前比较,差异均无统计学意义(P>0.05).治疗组治疗后BUT、SⅠT、瞬目频率及完全瞬目次数均高于对照组,不完全瞬目次数、FL评分、OSDI评分及结膜充血评分均低于对照组,差异均有统计学意义(P<0.05).(4)中医症候评分:2组治疗后中医症候评分均低于治疗前,差异均有统计学意义(P<0.05).治疗后,治疗组中医症候评分低于对照组,差异有统计学意义(P<0.05).(5)临床疗效:治疗组总有效率(94.87%)高于对照组(57.89%),差异有统计学意义(P<0.05).(6)安全性评价:治疗后,2组不良反应发生率比较,差异无统计学意义(P>0.05).结论 散结膏方对TED患者眼征、眼表指标及评分量表具有改善作用,可在临床推广使用.
OBJECTIVE To observe the clinical efficacy of Sanjie medicinal concoction in paste form(TCM)in treating thyroid eye disease(TED).METHODS A total of 77 patients(149 eyes)with TED of liver depression and blood stasis syndrome type who visited Nanjing Integrated Traditional Chinese and Western Medicine Hospital from March 2023 to March 2024 were enrolled.Participants were randomly divided into a treatment group(TG,39 cases,75 eyes)and a control group(CG,38 cases,74 eyes).The treatment group received oral Sanjie medicinal concoction in paste form(TCM),while the control group received oral Xiaoyao Pills,both for three months.Measurements included clinical activity score(CAS)for Graves'ophthalmopathy,proptosis,palpebral fissure height,upper eyelid retraction,lagophthalmos,blink frequency(complete and incomplete),ocular surface area,ocular surface area(OSA),conjunctival congestion score,corneal fluorescein staining(FL)score,tear film breakup time(BUT),Schirmer Ⅰ test(SⅠT),and ocular surface disease index(OSDI)score,recorded before and after treatment.RESULTS(1)Baseline thyroid parameters:No significant differences in free triiodothyronine,free thyroxine,thyroid-stimulating hormone,thyrotropin receptor antibody,thyroid peroxidase antibody,or thyroglobulin antibody were observed between groups before treatment(all P>0.05).(2)TED-related indicators:After treatment,the treatment group showed significant reductions in exophthalmos,palpebral fissure height,OSA,upper eyelid retraction,lagophthalmos,and CAS score compared to before treatment(all P<0.05).No statistically significant differences were found in the six TED-related indicators of the control group after treatment compared with those before treatment(P>0.05).After treatment,all six TED-related indicators in the treatment group were lower than those in the control group,the differences were all statistically significant(all P<0.05).(3)Dry eye-related indicators:After treatment,the treatment group showed significant increases in BUT,SⅠT,blink frequency and complete blink count,and significant decreases in incomplete blink count,FL scores,OSDI scores,and conjunctival congestion scores compared to before treatment(all P<0.05).No statistically significant differences were observed in all eight dry eye-related indicators of the control group after treatment compared with those before treatment(P>0.05).After treatment,the treatment group had significantly higher BUT,SⅠT,blink frequency,and complete blink count,and significantly lower incomplete blink count,FL scores,OSDI scores,and conjunctival congestion scores than the control group,the differences were all statistically significant(all P<0.05).(4)TCM syndrome scores:Both groups showed significant reductions in TCM syndrome scores after treatment(P<0.05).After treatment,the TCM syndrome scores were significantly lower in the treatment group than in the control group(P<0.05).(5)Clinical efficacy rate:The total effective rate was higher in the treatment group(94.87%)than that in the control group(57.89%),with significant difference(P<0.05).(6)Safety evaluation:No significant difference in adverse reaction rates was observed between the treatment group and control group(P>0.05).CONCLUSIONS Sanjie medicinal concoction in paste form(TCM)can improve the ocular signs,ocular surface indexes and score scales in patients with TED.
张永文;吕洁;韩欢欢;梅海云;南笑溪;储兰芳
南京中医药大学附属南京市中西医结合医院,南京 210014南京中医药大学附属南京市中西医结合医院,南京 210014南京中医药大学附属南京市中西医结合医院,南京 210014南京中医药大学附属南京市中西医结合医院,南京 210014南京中医药大学附属南京市中西医结合医院,南京 210014中国人民解放军东部战区总医院,南京 210012
医药卫生
缓消癥结甲状腺相关眼病散结膏方眼征眼表指标
gradually resolving massesthyroid eye diseaseSanjie medicinal concoction in paste form(TCM)ocular signsocular surface indices
《中国中医眼科杂志》 2026 (8)
732-738,744,8
评论